ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Aug 30, 2013
Insider Transaction Report
Form 4
Bender James G.
VP, Product Development & Mfg.
Transactions
- Exercise/Conversion
Common Stock
2013-08-28$0.95/sh+20,000$19,000→ 20,679 total - Sale
Common Stock
2013-08-28$2.85/sh−3,303$9,414→ 6,000 total - Sale
Common Stock
2013-08-28$2.88/sh−5,000$14,400→ 1,000 total - Sale
Common Stock
2013-08-29$3.00/sh−900$2,700→ 100 total - Tax Payment
Common Stock
2013-08-28$2.98/sh−6,376$19,000→ 14,303 total - Sale
Common Stock
2013-08-28$2.84/sh−5,000$14,200→ 9,303 total - Exercise/Conversion
Stock Option (right to buy)
2013-08-28−20,000→ 0 totalExercise: $0.95Exp: 2016-08-31→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Reflects 6,376 shares withheld by the Issuer at the market price of $2.98 per share less an exercise price of $0.95 per share to fund the cashless exercise of 20,000 options.
- [F2]The option vested in equal monthly installments of 3,000 shares monthly for five months following September 1, 2009, and as to 5,000 shares pursuant to achievement of a certain milestone.